INFOSOLUTIONS SVERIGE acquired by CARASENT
Context
Carasent's acquisition of Infosolutions reinforces its presence in the Swedish private healthcare market, driven by a vertical integration strategy to internalize a previously outsourced technological interoperability component, thereby securing control over the supplier's digital ecosystem. By acquiring the primary diagnostic routing network in the Swedish market, the acquirer gains exclusive control over the data exchange infrastructure that supports its own practice management software, eliminating the strategic risk of an independent middleware operator dictating connectivity standards or imposing price increases on critical data flows. The transaction marks the conversion of an autonomous connectivity editor into a captive infrastructure asset, with a post-closure integration agenda targeting immediate restructuring to align the target's profitability with the group's standards, by absorbing administrative support functions and gradually migrating historical billing flows to the acquirer's highly evolved SaaS revenue architecture. Meanwhile, control of this data highway provides the management team with a unique commercial lever to upsell its captive customer base with new proprietary clinical modules, leveraging end-to-end integration of radiological and biological prescription processes to displace peripheral niche software editors, and entering new markets through expanded service offerings. This transaction will be paid for 90% in cash and 10% in Caracent shares.
INFOSOLUTIONS SVERIGE, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the TMT (Tech, Media, Telecom) sector (14.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in TMT (Tech, Media, Telecom) market trends
Target
Infosolutions operates as an interoperability middleware provider that engineers and maintains secure diagnostic data routing networks specifically built for independent medical practices and private outpatient clinics. The corporate business model relies on monetizing a proprietary application programming interface (API) infrastructure that structurally bridges +1500 private healthcare facilities with a highly fragmented national ecosystem of commercial laboratories, public testing centers, and radiology departments. The enterprise derives its highly recurring cash flows through transactional routing fees and subscription contracts tied to the automated transmission of clinical orders, the logistical tracking of tissue samples, and the real-time ingestion of complex diagnostic imagery directly into localized Electronic Health Record (EHR) databases.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (SEK)
Similar deals in TMT (Tech, Media, Telecom)
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 03/2026 | ASMODEE GROUP | ATM GAMING | FRANCE | Software | Asmodee has finalized the acquisition of 100% of the French publisher ATM Gaming, marking the group's largest acquisition since its recent listing on the Stockholm stock exchange. The transaction is structured as a combinaison of cash payment, newly issued Asmodee shares, and a deferred payment component. This acquisition allows Asmodee to significantly reinforce its position in the "party game" category, which is currently seeing the highest growth rates in the industry. The group anticipates strong financial performance from the target, with Revenue and EBITDA projected to grow by 47% in 2026, reaching €50 million in sales and an EBITDA of €25 million, maintaining a robust 50% EBITDA margin |
| 03/2026 | MTIP | VERIFARMA | SPAIN | Software | MTIP has completed a majority strategic investment in Verifarma, a Spain,headquartered software provider. The transaction is designed to propel the next phase of the company's growth, with a specific focus on international scaling and technological advancement. All four co,founders, including the CEO, CFO, COO, and Chief AI Officer, will continue to lead the business post,investment, ensuring management continuity and the preservation of long,term customer relationships. The strategic rationale for the partnership involves significant investment in the core track,and,trace technology platform and the expansion of AI,driven quality management features |
| 02/2026 | VERTO GROWTH | MYTOWER | FRANCE | Software | Verto Growth acquired Reflexion Capital's minority stake in MyTower, becoming the new reference minority shareholder behind the majority management team. The sale process was managed by Rothschild & Co. Reflexion Capital exits with a gross money-on-money multiple of 4x and a net IRR of 38.7%, representing its first-ever portfolio exit. Verto's investment thesis centres on MyTower's modern technology stack, its strong positioning in the growing shipper TMS market, and its potential to become a reference European software platform through an active build-up strategy |
| 02/2026 | EXTENS | ORTHALIS & DENTALSOFT GROUP | FRANCE | Software | Extens structured a majority MBI to merge Orthalis and Dentalsoft into a new holding entity called SignalSoft Developpement. The project is led by Laurent Urien (CEO), who takes over from the exiting founders. The merger aims to create a dominant French platform with over EUR20M in revenue, focused on product innovation and international expansion into Switzerland, Italy, Spain, and Portugal. |
| 02/2026 | DOCTRINE | MAITE AI | SPAIN | Software | Doctrine's acquisition of Maite.ai represents a programmatic execution of its European market consolidation strategy, acquiring proprietary local data access and localized artificial intelligence capabilities to capture the fragmented Spanish legal services market. The transaction occurs at a critical operational inflection point for the target, which increased its annualized recurring revenue twentyfold over a twelve-month period under its founding team, exhausting its early-stage standalone capacity to efficiently service enterprise-grade law firms and public administrations |
| 02/2026 | CISION | TRAJAAN | FRANCE | Software | Cision acquired 100% of Trajaan to integrate advanced search intelligence and LLM analysis into its media intelligence suite. The deal follows a competitive process involving three potential buyers. The transaction provides an exit for the founders and business angels (who invested EUR650k in 2023). Trajaan will retain operational autonomy within Cision to leverage the group's massive distribution network. The valuation includes performance-based earn-outs over the coming years. |
| 01/2026 | CORILUS | SOFIA DEVELOPPEMENT | FRANCE | Software | Corilus acquired Sofia Developpement. This strategic cross-border merger creates a leading Franco-Belgian player with 70,000 users. The transaction marks a successful exit for IK Partners, which nearly doubled the company's valuation in two years through organic growth and key acquisitions (LogicMax, ComptaSante). |
| 01/2026 | TCV | PENNYLANE | FRANCE | Software | Pennylane raised EUR175M in a Series E funding round led by TCV and Blackstone. This round valued the company at approx. EUREUR3.5B. The funds are earmarked for product innovation (notably AI features) and accelerating market penetration among accounting firms. |
| 01/2026 | MONTEFIORE INVESTMENT / ACTIVA CAPITAL | ARCHE MC2 | FRANCE | Software | Montefiore Investment has entered into exclusive negotiations to acquire a joint-controlling equity stake in Arche MC2, forming an equal 50/50 partnership with the company's historical financial sponsor, Activa Capital. Choosing not to execute a full exit at this stage, Activa Capital has structured this co-investment framework to actively co-sponsor the platform's next growth cycle. Under the updated governance and capital structure, the internal management team will retain a minority equity stake, while Turenne Capital and Groupe Up will fully divest their respective holdings and exit the capital |
| 01/2026 | VERITAS CAPITAL | GLOBAL HEALTHCARE EXCHANGE | UNITED STATES | Software | Veritas Capital has acquired a majority stake in Global Healthcare Exchange (GHX), a leading supply chain software platform powering mission-critical connectivity between healthcare providers and suppliers. The acquisition will support the acceleration of GHX's growth strategy, with Veritas joining existing shareholders Temasek and Warburg Pincus. The strategic rationale behind the acquisition is to support GHX's vision of creating a more efficient, resilient, and interconnected healthcare system |
REFERENCES
Valuation range: EV 100M - 350M SEK
Revenue range: 50M - 100M SEK
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of INFOSOLUTIONS SVERIGE by CARASENT are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Press release: view release
Target: infosolutions sverige
Acquirer: carasent